Prognostic Utility of Total (68)Ga-DOTATATE-Avid Tumor Volume in Patients with Neuroendocrine Tumors

BACKGROUND & AIMS: Survival times vary among patients with neuroendocrine tumors (NETs)—even among those with the same site, stage, and grade of primary tumor. This makes it difficult to select treatment for patients with unresectable NETs, because some patients can survive decades without treat...

詳細記述

保存先:
書誌詳細
出版年:Gastroenterology
主要な著者: Tirosh, Amit, Papadakis, Georgios Z., Millo, Corina, Hammoud, Dima, Sadowski, Samira M., Herscovitch, Peter, Pacak, Karel, Marx, Stephen J., Yang, Lily, Nockel, Pavel, Shell, Jasmine, Green, Patience, Keutgen, Xavier M., Patel, Dhaval, Nilubol, Naris, Kebebew, Electron
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5847442/
https://ncbi.nlm.nih.gov/pubmed/29155309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2017.11.008
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料